Madrigal Pharmaceuticals, Inc. MDGL Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s change in inventories?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported change in inventories of $22.19M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s change in inventories increased by 4.8% year-over-year, from $21.17M to $22.19M.
- What does change in inventories mean?
- The change in the value of goods held in stock.
- How do you interpret change in inventories?
- A large increase may signal overproduction or slowing sales, while a decrease may indicate strong demand or supply constraints.
- How does change in inventories compare across companies?
- Highly dependent on the company's business model and inventory turnover ratios relative to competitors.